Skip to main content
Clinical Trials/CTRI/2022/09/045205
CTRI/2022/09/045205
Not yet recruiting
未知

Impact of Comprehensive Hypertension Intervention Program (CHIP) on biophysiological parameters, health related Quality of Life, Sleep Quality Index and Knowledge among patients with hypertension - A Randomized Controlled Trial.

Betcy George0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
Betcy George
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Betcy George

Eligibility Criteria

Inclusion Criteria

  • 1\.Adult hypertensive patients clinically diagnosed as stage 1 and stage 2 hypertension for past 1 year and above

Exclusion Criteria

  • Adults who are diagnosed with acute or chronic renal failure, neuro muscular or musculoskeletal abnormalities of upper limb, more than three blood pressure regulating agents or having well controlled hypertension.

Outcomes

Primary Outcomes

Not specified

Similar Trials